Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Micro Platform for Controlled Cardiac Myocyte Differentiation

  • Post author:
  • Post published:April 28, 2026
  • Post category:

Congestive heart failure, the inability of the heart to continue to pump effectively due to damage of its muscle cells, affects approximately 4.8 million Americans and is a leading cause…

Continue ReadingMicro Platform for Controlled Cardiac Myocyte Differentiation

Specification of Ventricular Myocyte and Pacemaker Lineages Utilizing Human Embryonic Stem Cells

  • Post author:
  • Post published:April 28, 2026
  • Post category:

Heart failure is a leading cause of mortality in California and the United States. Currently, there are no “cures” for heart failure.Other life threatening forms of heart disease include dysfunction…

Continue ReadingSpecification of Ventricular Myocyte and Pacemaker Lineages Utilizing Human Embryonic Stem Cells

Discovering Potent Molecules with Human ESCs to Treat Heart Disease

  • Post author:
  • Post published:April 28, 2026
  • Post category:

This work is directly relevant to human embryonic stem cell (hESC) research because it brings new ideas about novel compounds to affect cardiomyogenesis. The work addresses an urgent need to…

Continue ReadingDiscovering Potent Molecules with Human ESCs to Treat Heart Disease

Autologous cardiac-derived cells for advanced ischemic cardiomyopathy

  • Post author:
  • Post published:April 28, 2026
  • Post category:

The adult human heart contains small numbers of cardiac stem cells that are able to partially repair the heart following a heart attack or throughout the course of progressive heart…

Continue ReadingAutologous cardiac-derived cells for advanced ischemic cardiomyopathy

Human Cardiovascular Progenitors, their Niches and Control of Self-renewal and Cell Fate

  • Post author:
  • Post published:April 28, 2026
  • Post category:

For the millions of Americans who are born with or develop heart disease, stem cell research offers the first hope of reversing or repairing heart muscle damage. Thus, early reports…

Continue ReadingHuman Cardiovascular Progenitors, their Niches and Control of Self-renewal and Cell Fate

A First-in-Class CIRSPR-CasX Gene Editing Therapy for Lowering Lp(a) to Prevent Cardiovascular Events

  • Post author:
  • Post published:April 26, 2026
  • Post category:

Continue ReadingA First-in-Class CIRSPR-CasX Gene Editing Therapy for Lowering Lp(a) to Prevent Cardiovascular Events

TY1 and Semaglutide to Treat Cardiometabolic HFpEF

  • Post author:
  • Post published:April 26, 2026
  • Post category:

Continue ReadingTY1 and Semaglutide to Treat Cardiometabolic HFpEF

Noncoding RNA drug TY2 for arrhythmogenic cardiomyopathy

  • Post author:
  • Post published:April 26, 2026
  • Post category:

Continue ReadingNoncoding RNA drug TY2 for arrhythmogenic cardiomyopathy

A Center for Stem Cell Disease Modeling and Therapeutics

  • Post author:
  • Post published:April 26, 2026
  • Post category:

The goal of this project is to support the discovery and evaluation of novel therapeutics using stem cell-based models and drug and CRISPR screening. The facility will provide California researchers…

Continue ReadingA Center for Stem Cell Disease Modeling and Therapeutics

Stem Cell-based Disease Modeling Shared Resource Laboratory

  • Post author:
  • Post published:April 26, 2026
  • Post category:

Our Shared Resource Laboratory will expand access to stem cell-derived models to support research and educational programs with two main goals: democratize access to state-of-the-art models and technology among a…

Continue ReadingStem Cell-based Disease Modeling Shared Resource Laboratory
  • Go to the previous page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us